Avastin In MBC At Odds With Typical Medicare Coverage Of Off-Label Uses, CMS Official Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
Although CMS’ Jacques declined to speak directly about Medicare coverage plans for Avastin in breast cancer, his comments may shed some light on the direction the agency is leaning.